TfR1 interacts with the IKK complex and is involved in IKK-NF-κB signalling

Biochemical Journal

Volumn 449, Issue 1, 2013, Pages 275-284

  Kenneth, Niall S ^a,b   Mudie, Sharon ^a   Naron, Sanne ^a   Rocha, Sonia ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Inhibitor of nuclear factor B kinase (IKK); Iron; Nuclear factor B (NF B); Transferrin; Transferrin receptor 1 (TfR1); Tumour necrosis factor (TNF )

Indexed keywords

CD71 ANTIGEN; DEFEROXAMINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEOMICS; SIGNAL TRANSDUCTION;

ANTIGENS, CD; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; IRON; NF-KAPPA B; PROTEIN BINDING; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION;

EID: 84870891464     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120625     Document Type: Article

References (42)

1. Perkins, N. D. (2012) The diverse and complex roles of NF-κB subunits in cancer. Nat. Rev. Cancer 12, 121-132
2. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62
3. Israel, A. (2010) The IKK complex, a central regulator of NF-κB activation. Cold Spring Harbor Perspect. Biol. 2, a000158
4. Wertz, I. E. and Dixit, V. M. (2010) Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harbor Perspect. Biol. 2, a003350
5. Comb, W. C., Cogswell, P., Sitcheran, R. and Baldwin, A. S. (2011) IKK-dependent, NF-κB-independent control of autophagic gene expression. Oncogene 30, 1727-1732
6. Criollo, A., Senovilla, L., Authier, H., Maiuri, M. C., Morselli, E., Vitale, I., Kepp, O., Tasdemir, E., Galluzzi, L., Shen, S. et al. (2010) IKK connects autophagy to major stress pathways. Autophagy 6, 189-191
7. Criollo, A., Senovilla, L., Authier, H., Maiuri, M. C., Morselli, E., Vitale, I., Kepp, O., Tasdemir, E., Galluzzi, L., Shen, S. et al. (2010) The IKK complex contributes to the induction of autophagy. EMBO J. 29, 619-631
8. Chariot, A. (2009) The NF-κB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol. 19, 404-413
9. Poyet, J. L., Srinivasula, S. M., Lin, J. H., Fernandes-Alnemri, T., Yamaoka, S., Tsichlis, P. N. and Alnemri, E. S. (2000) Activation of the IκB kinases by RIP via IKKγ/NEMO-mediated oligomerization. J. Biol. Chem. 275, 37966-37977 (Pubitemid 32004918)
10. Broemer, M., Krappmann, D. and Scheidereit, C. (2004) Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 23, 5378-5386 (Pubitemid 39005813)
11. Ducut Sigala, J. L., Bottero, V., Young, D. B., Shevchenko, A., Mercurio, F. and Verma, I. M. (2004) Activation of transcription factor NF-κB requires ELKS, an IκB kinase regulatory subunit. Science 304, 1963-1967 (Pubitemid 38822188)
12. 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. 8, 398-406
13. van Uden, P., Kenneth, N. S., Webster, R., Muller, H. A., Mudie, S. and Rocha, S. (2011) Evolutionary conserved regulation of HIF-1β by NF-κB. PLoS Genet. 7, e1001285
14. Kenneth, N. S., Mudie, S. and Rocha, S. (2010) IKK and NF-κB-mediated regulation of Claspin impacts on ATR checkpoint function. EMBO J. 29, 2966-2978
15. Rocha, S., Campbell, K. J. and Perkins, N. D. (2003) p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor. Mol. Cell 12, 15-25 (Pubitemid 36945034)
16. Melvin, A., Mudie, S. and Rocha, S. (2011) The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Mol. Biol. Cell 22, 4171-4181
17. Wang, S. J., Gao, C. and Chen, B. A. (2010) Advancement of the study on iron metabolism and regulation in tumor cells. Chin. J. Cancer 29, 451-455
18. Munoz, M., Garcia-Erce, J. A. and Remacha, A. F. (2011) Disorders of iron metabolism. Part II: iron deficiency and iron overload. J. Clin. Pathol. 64, 287-296
19. Munoz, M., Garcia-Erce, J. A. and Remacha, A. F. (2011) Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J. Clin. Pathol. 64, 281-286
20. Nelson, D. E., Ihekwaba, A. E., Elliott, M., Johnson, J. R., Gibney, C. A., Foreman, B. E., Nelson, G., See, V., Horton, C. A., Spiller, D. G. et al. (2004) Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704-708 (Pubitemid 39440922)
21. Ashall, L., Horton, C. A., Nelson, D. E., Paszek, P., Harper, C. V., Sillitoe, K., Ryan, S., Spiller, D. G., Unitt, J. F., Broomhead, D. S. et al. (2009) Pulsatile stimulation determines timing and specificity of NF-κB-dependent transcription. Science 324, 242-246
22. Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T. and Saiki, I. (2003) Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278, 36916-36923 (Pubitemid 37140026)
23. Tacchini, L., Gammella, E., De Ponti, C., Recalcati, S. and Cairo, G. (2008) Role of HIF-1 and NF-κB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283, 20674-20686
24. Magro, G., Cataldo, I., Amico, P., Torrisi, A., Vecchio, G. M., Parenti, R., Asioli, S., Recupero, D., D'Agata, V., Mucignat, M. T. and Perris, R. (2011) Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid 21, 267-277
25. Daniels, T. R., Bernabeu, E., Rodriguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G. and Penichet, M. L. (2012) The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim. Biophys. Acta 1820, 291-317
26. Pandey, M. K., Sung, B., Ahn, K. S., Kunnumakkara, A. B., Chaturvedi, M. M. and Aggarwal, B. B. (2007) Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway. Blood 110, 3517-3525 (Pubitemid 350159615)
27. Palempalli, U. D., Gandhi, U., Kalantari, P., Vunta, H., Arner, R. J., Narayan, V., Ravindran, A. and Prabhu, K. S. (2009) Gambogic acid covalently modifies IκB kinase-β subunit to mediate suppression of lipopolysaccharide-induced activation of NF-κB in macrophages. Biochem. J. 419, 401-409
28. Kasibhatla, S., Jessen, K. A., Maliartchouk, S., Wang, J. Y., English, N. M., Drewe, J., Qiu, L., Archer, S. P., Ponce, A. E., Sirisoma, N. et al. (2005) A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc. Natl. Acad. Sci. U.S.A. 102, 12095-12100 (Pubitemid 41291134)
29. Lu, L., Tang, D., Wang, L., Huang, L. Q., Jiang, G. S., Xiao, X. Y. and Zeng, F. Q. (2012) Gambogic acid inhibits TNF-α-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-κB signaling pathways. Acta Pharmacol. Sin. 33, 531-541
30. Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P. O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S. et al. (2004) A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat. Cell Biol. 6, 97-105 (Pubitemid 38425708)
31. Clark, K., Peggie, M., Plater, L., Sorcek, R. J., Young, E. R., Madwed, J. B., Hough, J., McIver, E. G. and Cohen, P. (2011) Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434, 93-104
32. Clark, K., Takeuchi, O., Akira, S. and Cohen, P. (2011) The TRAF-associated protein TANK facilitates cross-talk within the IκB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 17093-17098
33. Zhang, L., Yi, Y., Chen, J., Sun, Y., Guo, Q., Zheng, Z. and Song, S. (2010) Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells. Biochem. Biophys. Res. Commun. 403, 282-287
34. phox protein expression and NADPH oxidase activity. Arterioscler. Thromb. Vasc. Biol. 26, 2638-2643
35. Messa, E., Carturan, S., Maffe, C., Pautasso, M., Bracco, E., Roetto, A., Messa, F., Arruga, F., Defilippi, I., Rosso, V. et al. (2010) Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging. Haematologica 95, 1308-1316
36. Ornstein, D. L. and Zacharski, L. R. (2007) Iron stimulates urokinase plasminogen activator expression and activates NF-κB in human prostate cancer cells. Nutr. Cancer 58, 115-126 (Pubitemid 47078897)
37. van Uden, P., Kenneth, N. S. and Rocha, S. (2008) Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem. J. 412, 477-484
38. Li, Z. W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999) The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J. Exp. Med. 189, 1839-1845 (Pubitemid 29272700)
39. Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L. and Goeddel, D. V. (1999) Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10, 421-429 (Pubitemid 29205478)
40. Rudolph, D., Yeh, W. C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J. and Mak, T. W. (2000) Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14, 854-862 (Pubitemid 30215004)
41. Geisler, F., Algul, H., Paxian, S. and Schmid, R. M. (2007) Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132, 2489-2503 (Pubitemid 46890861)
42. Perkins, N. D. and Gilmore, T. D. (2006) Good cop, bad cop: the different faces of NF-κB. Cell Death Differ. 13, 759-772